← Back to Search

Vitrectomy Probe

Vista Probe for Vitrectomy

N/A

Waitlist Available

Research Sponsored by VISTA Ophthalmics

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up month 1

Awards & highlights

Study Summary

This trial will study the safety and performance of a vitrectomy probe used in eye surgery.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ month 1

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~month 1

This trial's timeline: 3 weeks for screening, Varies for treatment, and month 1 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Incidence of choroidal detachment

Incidence of endophthalmitis

Incidence of ocular hypotony

+4 more

Secondary outcome measures

Percentage of eyes with clinical evidence of incomplete vitrectomy, such as vitreous strands or pupil peaking

Surgeon- will assess device adequacy for removal of vitreous

Trial Design

1Treatment groups

Experimental Treatment

Group I: 27 GA Vista Ophthalmics vitrectorExperimental Treatment1 Intervention

The vitrectomy will be performed through the pars plana using the 27 GA Vista Ophthalmics vitrector.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

VISTA OphthalmicsLead Sponsor

CBCC Global ResearchNETWORK

7 Previous Clinical Trials

1,251 Total Patients Enrolled

Don KnowlesStudy ChairVISTA Ophthalmics

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment for this research project still ongoing?

"This medical trial is actively enrolling participants, as indicated on clinicaltrials.gov which shows the protocol was initially uploaded on December 9th 2022 and most recently edited January 16th 2023."

Answered by AI

How many geographic locations are offering access to this research program?

"Four facilities are currently running this study, situated in Bradenton, Bala-Cynwyd and McAllen plus one other. To reduce the amount of travelling involved, it's wise to pick a site closest to you if you're interested in taking part."

Answered by AI

What is the current enrollment figure for this experiment?

"The sponsor of this study, VISTA Ophthalmics, needs 50 participants that meet the eligibility criteria. Two primary sites to execute the trial are CBCC Global Research Site:002 in Bradenton, Florida and CBCC Global Research Site:001 located in Bala-Cynwyd Pennsylvania."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Study to Evaluate the Safety and Performance of the Vista Probe for Vitrectomy Surgery

2022. "A Study to Evaluate the Safety and Performance of the Vista Probe for Vitrectomy Surgery". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05689333.